Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
Author Information
Author(s): Roberto Scatena, Patrizia Bottoni, Bruno Giardina
Primary Institution: Catholic University, Rome, Italy
Hypothesis
The study investigates the role of receptor-independent actions of PPAR agonists in cancer biology.
Conclusion
PPAR ligands can induce oxidative stress and have complex roles in cancer cell differentiation and metabolism.
Supporting Evidence
- PPAR ligands can induce oxidative stress, which is linked to cancer.
- Some PPAR ligands have been shown to promote cancer cell differentiation.
- Fibrates and thiazolidinediones can disrupt mitochondrial function.
- Oxidative stress from PPAR ligands may contribute to carcinogenesis.
- Species-specific differences in metabolism can complicate the application of rodent study results to humans.
Takeaway
Some medicines that help with diabetes might also affect how cancer cells grow, and they can do this in ways that don't involve their usual targets in the body.
Methodology
The review discusses various studies on PPAR ligands and their effects on cancer cells, focusing on mitochondrial interactions.
Potential Biases
Potential bias in interpreting the effects of PPAR ligands due to the complexity of their actions.
Limitations
The findings from rodent studies may not directly apply to humans due to species-specific differences.
Statistical Information
P-Value
0.032
Statistical Significance
p=0.032
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website